Pardoprunox hydrochloride is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.
For research use only. We do not sell to patients.
Chemical Information
| Name | Pardoprunox hydrochloride |
| Iupac Chemical Name | 7-(4-methylpiperazin-1-yl)-3H-1,3-benzoxazol-2-one;hydrochloride |
| Synonyms | SLV-308 hydrochloride; DU-126891 hydrochloride |
| Molecular Formula | C12H16ClN3O2 |
| Molecular Weight | 269.727 |
| Smile | CN1CCN(CC1)C2=CC=CC3=C2OC(=O)N3.Cl |
| InChiKey | NQRIKTDKFHAOKC-UHFFFAOYSA-N |
| InChi | InChI=1S/C12H15N3O2.ClH/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9;/h2-4H,5-8H2,1H3,(H,13,16);1H |
| CAS Number | 269718-83-4 |
| Related CAS | |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
| Bulk | | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |